Sign in
LFCR Stock Price, Chart, Stats & News
Lifecore Biomedical, Inc.
Save
211.55M
Market cap
–
Current P/E
8.67x
Forward P/E
LFCR chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 32.30% |
Operating margin | -3.01% |
Pretax margin | -22.78% |
Net margin | -23.03% |
Effective tax rate | -1.08% |
ROA | -14.59% |
ROE | -182.11% |
D/E | 4.23x |
Interest coverage ratio | -0.21x |
LFCR valuation
P/E | – |
P/S | 0.93x |
P/B | 4.03x |
P/CF | 9.88x |
P/FCF | 52.19x |
P/OCF | 9.88x |
PEG | -0.04x |
EV multiple | -5.03x |
About
Lifecore Biomedical, Inc. (LFCR) operates as a multifaceted contract development and manufacturing organization (CDMO) with a global presence, conducting business through its various subsidiaries. The company's operations are divided into three core segments: Lifecore, Curation Foods, and Other. The Lifecore division is primarily responsible for the production of pharmaceutical-grade sodium hyaluronate (HA) in bulk quantities.
Similar securities
Based on sector and market capitalization
Report issue